Strategic Transformation of the Market of HCV Treatments

NCT02961426 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
UNKNOWN
Status
603
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Drugs for Neglected Diseases

Collaborators